Startup India Government of India
Neomaxx Pharmaceuticals Private Limited
Neomaxx Pharmaceuticals Private Limited - chemicals in Hubli, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹95.56 Lakh
▼ 3% YoY
Net profit · FY 2025
₹2.4 Lakh
Net margin 2.5%
EBITDA · FY 2025
₹8.93 Lakh
EBITDA margin 9.3%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹4 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
7
As per MCA filings
Active GSTINs
1
GST registered
About Neomaxx Pharmaceuticals Private Limited
Data last updated:
Neomaxx Pharmaceuticals Private Limited is a private limited company based in Hubli, Karnataka, India, recognised as a startup by DPIIT. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 20 September 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24230KA2019PTC128124. Its GSTIN is 29AAGCN6907Q1ZM (Karnataka).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors including Drsuresh Yeshwanth Patil and Narasimhan Raju.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shivalingamma Heerad Memorial Complex 3 Floor 3 Cross Hosur, Hubli, Karnataka, India – 580021.
As per the financials filed for FY 2025, the company reported a revenue of ₹95.56 Lakh, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹2.4 Lakh (net margin 2.5%) and EBITDA of ₹8.93 Lakh (EBITDA margin 9.3%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years.
Neomaxx Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-13-0017214).
Company details
CIN U24230KA2019PTC128124
Registration Number 128124
Incorporation Date 20 September 2019
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-KR-13-0017214
Key People
Drsuresh Yeshwanth Patil Director Narasimhan Raju Director Bramhavar Shamburao Ramesh Director Recognitions & Rankings of Neomaxx Pharmaceuticals
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-KR-13-0017214
Contact details
Neomaxx Pharmaceuticals Private Limited's registered office is in Hubli, Karnataka. Its e-mail address is in the company report.
- Email
- Registered AddressShivalingamma Heerad Memorial Complex 3 Floor 3 Cross Hosur, Hubli, Karnataka, India – 580021
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Neomaxx Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Neomaxx Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Neomaxx Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Neomaxx Pharmaceuticals Private Limited, buy the company report.
Financials of Neomaxx Pharmaceuticals Private Limited
FY 2025 filings availableNeomaxx Pharmaceuticals Private Limited reported revenue of ₹95.56 Lakh (down 3% YoY) for FY 2025.
Revenue · FY 2025
₹95.56 Lakh ▼ 3%
Net profit · FY 2025
₹2.4 Lakh margin 2.5%
EBITDA · FY 2025
₹8.93 Lakh margin 9.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 3%
3 years · compounded
▲ 16%
EBITDA CAGR growth
1 year
▲ 2%
3 years · compounded
▲ 39%
5 years · compounded
▲ 41%
Revenue fell 3% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 16%. EBITDA rose 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.93 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.4 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.3% | ||||
| Net Profit Margin | 2.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Neomaxx Pharmaceuticals Private Limited, buy the company report.
Board of directors of Neomaxx Pharmaceuticals Private Limited
Neomaxx Pharmaceuticals has 7 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Drsuresh Yeshwanth Patil Also directs: Kalaburagi Super Speciality Hospital Private Limited | Director | 20 Sep 2019 | 7 Years 1 Months | Current |
| Narasimhan Raju | Director | 21 Mar 2020 | 6 Years 7 Months | Current |
| Bramhavar Shamburao Ramesh | Director | 21 Mar 2020 | 6 Years 7 Months | Current |
| Vishnu Prabhu | Director | 21 Mar 2020 | 6 Years 7 Months | Current |
| Sharanabasappa Kamreddy Also directs: Kalaburagi Super Speciality Hospital Private Limited | Director | 21 Mar 2020 | 6 Years 7 Months | Current |
| Prashant Shivappa Holkunde Also directs: Aaryavedanta Scan Centre LLP, Dharwad Scan Centre LLP, Sanchaya Pharmaceuticals LLP and 1 more | Director | 20 Sep 2019 | 7 Years 1 Months | Current |
Showing 6 of 7 current directors. View all directors
Legal cases
No court or tribunal cases involving Neomaxx Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Neomaxx Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Neomaxx Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAGCN6907Q1ZM | Karnataka | Active | 06 Mar 2020 |
To see the full GST registrations and return filing status of Neomaxx Pharmaceuticals Private Limited, buy the company report.
Recent activity
Neomaxx Pharmaceuticals Private Limited has 8 board changes on record since 2019: 7 appointments and 1 cessation. The latest: Prabhakar Shankaran ceased to be Director on 07 Mar 2024.
AGM
Neomaxx Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Neomaxx Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Ceased
Prabhakar Shankaran ceased to be Director.
Appointed
Basalingappa Channabasappa Navadgi was appointed as Director.
Appointed
Bramhavar Shamburao Ramesh was appointed as Director.
Appointed
Narasimhan Raju was appointed as Director.
Appointed
Sharanabasappa Kamreddy was appointed as Director.
Appointed
Vishnu Prabhu was appointed as Director.
Appointed
Drsuresh Yeshwanth Patil was appointed as Director.
Appointed
Prashant Shivappa Holkunde was appointed as Director.
Incorporation
20 Sep 2019
Neomaxx Pharmaceuticals Private Limited was registered on 20 Sep 2019 with Roc Bangalore & aged 7 years 1 month as per MCA records.
Frequently asked questions
Neomaxx Pharmaceuticals is an active private limited company based in Hubli, Karnataka, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 20 September 2019 (7+ years old) and is registered under CIN U24230KA2019PTC128124.
Neomaxx Pharmaceuticals has 7 current directors:
- Drsuresh Yeshwanth Patil - Director
- Narasimhan Raju - Director
- Bramhavar Shamburao Ramesh - Director
- Vishnu Prabhu - Director
- Sharanabasappa Kamreddy - Director
- Prashant Shivappa Holkunde - Director
- Basalingappa Channabasappa Navadgi - Director
The latest financial statements of Neomaxx Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Neomaxx Pharmaceuticals is 29AAGCN6907Q1ZM, registered in Karnataka.
The CIN (Corporate Identification Number) of Neomaxx Pharmaceuticals is U24230KA2019PTC128124. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neomaxx Pharmaceuticals was incorporated on 20 September 2019, making it 7+ years old. It is registered with the Registrar of Companies, Bangalore.
Prabhakar Shankaran ceased to be Director on 07 Mar 2024. Basalingappa Channabasappa Navadgi was appointed as Director on 30 Jan 2022. Bramhavar Shamburao Ramesh was appointed as Director on 21 Mar 2020. Neomaxx Pharmaceuticals has 8 board changes on record in total.
Yes, Neomaxx Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Neomaxx Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-13-0017214).
The registered office of Neomaxx Pharmaceuticals is at Shivalingamma Heerad Memorial Complex 3 Floor 3 Cross Hosur, Hubli, Karnataka, India – 580021.